Standard Biotools (LAB) Gains from Investment Securities (2024 - 2025)
Standard Biotools (LAB) posted quarterly Gains from Investment Securities of -$2.9 million for Q4 2025, down 721.31% year-over-year from $474000.0 in Q4 2024, and down 192.96% quarter-over-quarter from $3.2 million in Q2 2025.
Standard Biotools (LAB) Gains from Investment Securities (2024 - 2025) Analysis & Trends
Standard Biotools (LAB) has reported Gains from Investment Securities for 2 consecutive years, with -$2.9 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Gains from Investment Securities fell 721.31% year-over-year to -$2.9 million; the TTM figure through Mar 2026 stood at $223000.0 (up 105.24% YoY), while the FY2025 annual figure was -$3.2 million, changed N/A from the prior year.
- Gains from Investment Securities retreated to -$2.9 million in Q4 2025 per LAB's latest filing, from $3.2 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $3.2 million in Q2 2025 and bottomed at -$3.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Standard Biotools | 250.59 Mn | -226.13 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.95 Mn |
| Dec 31, 2025 | -2.95 Mn |
| Jun 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 3.17 Mn |
| Mar 31, 2025 | -3.40 Mn |
| Mar 31, 2025 | -3.40 Mn |
| Dec 31, 2024 | 474,000.00 |
| Dec 31, 2024 | 474,000.00 |
| Sep 30, 2024 | -474,000.00 |
| Sep 30, 2024 | -474,000.00 |
| Jun 30, 2024 | -853,000.00 |
| Jun 30, 2024 | -853,000.00 |
| Mar 31, 2024 | 853,000.00 |
| Mar 31, 2024 | 853,000.00 |